Lexiscan Administration Protocol
Administer Lexiscan (regadenoson) as a fixed 0.4 mg dose (5 mL) via rapid intravenous bolus over 10 seconds into a peripheral vein, followed immediately by a 5 mL saline flush, with the radionuclide imaging agent given 10-20 seconds after the saline flush. 1
Pre-Administration Requirements
Patient preparation is critical:
- Instruct patients to avoid all methylxanthine-containing products for at least 12 hours before the procedure, including caffeinated coffee, tea, other caffeinated beverages, caffeine-containing drugs, aminophylline, and theophylline 1
- Visually inspect the solution for particulate matter or discoloration; do not administer if either is present 1
- Ensure cardiac resuscitation equipment and trained staff are immediately available before administration 1
Administration Technique
The injection protocol must be precise:
- Use a 22-gauge or larger catheter or needle for peripheral venous access 1
- Inject the entire 5 mL (0.4 mg) dose over exactly 10 seconds—not faster or slower 1
- Immediately follow with a 5 mL saline flush 1
- Administer the radionuclide myocardial perfusion imaging agent 10-20 seconds after the saline flush 1
- The radionuclide may be injected directly into the same catheter used for Lexiscan 1
Key advantage: Regadenoson requires no infusion pump and is administered by hand-held syringe, unlike adenosine which requires weight-based dosing and an infusion pump 2. The fixed bolus dose simplifies workflow significantly 2.
Timing for Image Acquisition
Optimal imaging window is 2-4 minutes after drug infusion for perfusion imaging 2. This differs from adenosine, where peak vasodilatory effect occurs at the end of infusion, whereas regadenoson's selective A2a receptor agonism produces effects that persist longer 2.
Critical Safety Considerations
Absolute contraindications:
- Second- or third-degree AV block 1
- Sinus node dysfunction (unless patient has a functioning artificial pacemaker) 1
High-risk situations requiring extreme caution:
- Avoid use in patients with acute myocardial ischemia symptoms, unstable angina, or cardiovascular instability—these patients are at greater risk for fatal/nonfatal MI, ventricular arrhythmias, and cardiac arrest 1
- Critical pitfall: The 10-second injection time matters—longer injection times may increase the duration and magnitude of coronary blood flow increase, potentially increasing risk 1
Reversal Agent Availability
Have aminophylline immediately available as an adenosine antagonist to shorten the duration of increased coronary blood flow if serious reactions occur 1. Aminophylline should be administered slowly, starting with 70 mg over 1 minute, up to a maximum of 240 mg over 3 minutes as a slow bolus—avoid fast injections as the drug is potentially arrhythmogenic 2.
Advantages Over Alternative Vasodilators
Regadenoson's selective A2a receptor agonism avoids or reduces undesirable effects of A1, A2B, and A3-receptor stimulation (dyspnea, bronchospasm, headache, flushing) 2. While more expensive than other vasodilators, the fixed bolus dose without weight-based adjustment and no need for an infusion pump simplifies the workflow considerably 2.